Pfizer Inc. (PFE)
USD 24.2
(1.13%)
USD 24.2
(1.13%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 9.55 Billion USD | -75.88% |
| 2022 | 41.03 Billion USD | 52.94% |
| 2021 | 30.79 Billion USD | 102.85% |
| 2020 | 13.16 Billion USD | -28.77% |
| 2019 | 18.85 Billion USD | -7.78% |
| 2018 | 19.58 Billion USD | 5.81% |
| 2017 | 19.84 Billion USD | 6.09% |
| 2016 | 15.29 Billion USD | 7.82% |
| 2015 | 15.32 Billion USD | -8.0% |
| 2014 | 19.13 Billion USD | -12.29% |
| 2013 | 23.54 Billion USD | -12.46% |
| 2012 | 20.41 Billion USD | -14.15% |
| 2011 | 22.18 Billion USD | 26.58% |
| 2010 | 19.56 Billion USD | 2.37% |
| 2009 | 16.81 Billion USD | -14.19% |
| 2008 | 15.3 Billion USD | 48.28% |
| 2007 | 15.53 Billion USD | -16.8% |
| 2006 | 19.57 Billion USD | -11.98% |
| 2005 | 19.78 Billion USD | -3.87% |
| 2004 | 21.52 Billion USD | 11.75% |
| 2003 | 14.39 Billion USD | 61.49% |
| 2002 | 13.25 Billion USD | 7.43% |
| 2001 | 11.58 Billion USD | 2.09% |
| 2000 | 9.53 Billion USD | 144.59% |
| 1999 | 7.86 Billion USD | 1.78% |
| 1998 | 6.14 Billion USD | 24.23% |
| 1997 | 3.5 Billion USD | 8.45% |
| 1996 | 3.1 Billion USD | 18.49% |
| 1995 | 2.93 Billion USD | 34.51% |
| 1994 | 2.26 Billion USD | 110.8% |
| 1993 | 1.17 Billion USD | -25.49% |
| 1992 | 1.7 Billion USD | -9.83% |
| 1991 | 1.49 Billion USD | 17.13% |
| 1990 | 1.27 Billion USD | 8.79% |
| 1989 | 1.17 Billion USD | -2.58% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 6.29 Billion USD | 435.86% |
| 2024 Q2 | 3.61 Billion USD | -59.57% |
| 2024 Q3 | 5.5 Billion USD | 201.58% |
| 2023 FY | - USD | -75.88% |
| 2023 Q1 | 7.86 Billion USD | 4.06% |
| 2023 Q2 | 3.65 Billion USD | -53.6% |
| 2023 Q3 | -1.7 Billion USD | -146.7% |
| 2023 Q4 | 77 Million USD | 104.52% |
| 2022 Q3 | 11.24 Billion USD | -20.34% |
| 2022 Q1 | 11.52 Billion USD | 106.91% |
| 2022 Q2 | 14.12 Billion USD | 22.58% |
| 2022 FY | - USD | 52.94% |
| 2022 Q4 | 7.56 Billion USD | -32.78% |
| 2021 Q1 | 6.29 Billion USD | 161.96% |
| 2021 Q2 | 7.34 Billion USD | 16.68% |
| 2021 Q4 | 5.56 Billion USD | -40.51% |
| 2021 Q3 | 9.36 Billion USD | 27.43% |
| 2021 FY | - USD | 102.85% |
| 2020 Q1 | 5.37 Billion USD | 69.63% |
| 2020 Q4 | 2.4 Billion USD | -46.24% |
| 2020 Q3 | 4.47 Billion USD | -6.45% |
| 2020 Q2 | 4.77 Billion USD | -11.09% |
| 2020 FY | - USD | -28.77% |
| 2019 Q1 | 6.13 Billion USD | 28.65% |
| 2019 FY | - USD | -7.78% |
| 2019 Q4 | 3.16 Billion USD | -33.26% |
| 2019 Q3 | 4.74 Billion USD | -16.76% |
| 2019 Q2 | 5.7 Billion USD | -6.97% |
| 2018 Q2 | 5.25 Billion USD | -2.52% |
| 2018 Q1 | 5.39 Billion USD | 38.16% |
| 2018 FY | - USD | 5.81% |
| 2018 Q4 | 4.76 Billion USD | -8.14% |
| 2018 Q3 | 5.18 Billion USD | -1.29% |
| 2017 Q1 | 5.54 Billion USD | 54.74% |
| 2017 Q4 | 3.9 Billion USD | -27.65% |
| 2017 Q3 | 5.39 Billion USD | 0.04% |
| 2017 Q2 | 5.39 Billion USD | -2.85% |
| 2017 FY | - USD | 6.09% |
| 2016 FY | - USD | 7.82% |
| 2016 Q4 | 3.58 Billion USD | -27.28% |
| 2016 Q2 | 5.08 Billion USD | -6.89% |
| 2016 Q3 | 4.93 Billion USD | -3.03% |
| 2016 Q1 | 5.46 Billion USD | 66.24% |
| 2015 Q1 | 4.31 Billion USD | 18.27% |
| 2015 Q2 | 4.94 Billion USD | 14.5% |
| 2015 Q3 | 5.15 Billion USD | 4.21% |
| 2015 FY | - USD | -8.0% |
| 2015 Q4 | 3.28 Billion USD | -36.23% |
| 2014 Q3 | 5.1 Billion USD | -5.41% |
| 2014 Q2 | 5.39 Billion USD | 8.49% |
| 2014 Q1 | 4.97 Billion USD | -4.55% |
| 2014 FY | - USD | -12.29% |
| 2014 Q4 | 3.65 Billion USD | -28.45% |
| 2013 Q4 | 5.2 Billion USD | -8.15% |
| 2013 Q3 | 5.67 Billion USD | -2.29% |
| 2013 Q2 | 5.8 Billion USD | -2.86% |
| 2013 FY | - USD | -12.46% |
| 2013 Q1 | 5.97 Billion USD | 4.15% |
| 2012 Q1 | 8.47 Billion USD | 40.57% |
| 2012 Q2 | 6.15 Billion USD | -27.41% |
| 2012 Q3 | 6.74 Billion USD | 9.62% |
| 2012 Q4 | 5.73 Billion USD | -14.98% |
| 2012 FY | - USD | -14.15% |
| 2011 Q2 | 6.03 Billion USD | -3.93% |
| 2011 FY | - USD | 26.58% |
| 2011 Q4 | 6.03 Billion USD | -4.06% |
| 2011 Q3 | 6.28 Billion USD | 4.18% |
| 2011 Q1 | 6.28 Billion USD | 40.95% |
| 2010 Q1 | 6.14 Billion USD | 35.24% |
| 2010 FY | - USD | 2.37% |
| 2010 Q4 | 4.45 Billion USD | 24.01% |
| 2010 Q3 | 3.59 Billion USD | -49.76% |
| 2010 Q2 | 7.15 Billion USD | 16.35% |
| 2009 Q4 | 4.54 Billion USD | -8.18% |
| 2009 Q2 | 4.55 Billion USD | -17.11% |
| 2009 Q1 | 5.48 Billion USD | -41.93% |
| 2009 Q3 | 4.95 Billion USD | 8.81% |
| 2009 FY | - USD | -14.19% |
| 2008 Q4 | 9.45 Billion USD | 54.51% |
| 2008 Q2 | 5.13 Billion USD | -7.14% |
| 2008 FY | - USD | 48.28% |
| 2008 Q3 | 6.11 Billion USD | 19.14% |
| 2008 Q1 | 5.53 Billion USD | 25.77% |
| 2007 Q1 | 6.71 Billion USD | 29.44% |
| 2007 Q3 | 2.39 Billion USD | -42.74% |
| 2007 FY | - USD | -16.8% |
| 2007 Q2 | 4.18 Billion USD | -37.59% |
| 2007 Q4 | 4.39 Billion USD | 83.36% |
| 2006 Q4 | 5.18 Billion USD | 1.55% |
| 2006 Q2 | 5.27 Billion USD | -9.85% |
| 2006 Q1 | 5.84 Billion USD | 4.11% |
| 2006 FY | - USD | -11.98% |
| 2006 Q3 | 5.1 Billion USD | -3.13% |
| 2005 Q3 | 6.63 Billion USD | 29.61% |
| 2005 Q2 | 5.11 Billion USD | -24.68% |
| 2005 Q1 | 6.79 Billion USD | -5.65% |
| 2005 FY | - USD | -3.87% |
| 2005 Q4 | 5.61 Billion USD | -15.33% |
| 2004 FY | - USD | 11.75% |
| 2004 Q4 | 7.2 Billion USD | 16.86% |
| 2004 Q3 | 6.16 Billion USD | 21.83% |
| 2004 Q2 | 5.05 Billion USD | -39.45% |
| 2004 Q1 | 8.35 Billion USD | 30.94% |
| 2003 Q2 | 2.8 Billion USD | 100.71% |
| 2003 Q4 | 4.54 Billion USD | 65.8% |
| 2003 Q3 | 3.68 Billion USD | -52.86% |
| 2003 FY | - USD | 61.49% |
| 2003 Q1 | 3.76 Billion USD | 7.74% |
| 2002 FY | - USD | 7.43% |
| 2002 Q3 | 3.31 Billion USD | 22.68% |
| 2002 Q1 | 3.32 Billion USD | 6.12% |
| 2002 Q4 | 3.54 Billion USD | 3.09% |
| 2002 Q2 | 2.71 Billion USD | -14.74% |
| 2001 Q1 | 3.04 Billion USD | 6.53% |
| 2001 Q2 | 2.85 Billion USD | -5.77% |
| 2001 Q4 | 3.05 Billion USD | 2.01% |
| 2001 FY | - USD | 2.09% |
| 2001 Q3 | 3.08 Billion USD | 3.65% |
| 2000 Q2 | 2.1 Billion USD | 74.97% |
| 2000 FY | - USD | 144.59% |
| 2000 Q4 | 2.55 Billion USD | 2.74% |
| 2000 Q3 | 2.47 Billion USD | 20.57% |
| 2000 Q1 | 2.37 Billion USD | -2.38% |
| 1999 Q1 | 1.28 Billion USD | -3.01% |
| 1999 Q3 | 1.79 Billion USD | -2.11% |
| 1999 FY | - USD | 1.78% |
| 1999 Q2 | 2.01 Billion USD | -4.73% |
| 1999 Q4 | 1.46 Billion USD | 22.01% |
| 1998 Q1 | 1.03 Billion USD | 6.26% |
| 1998 FY | - USD | 24.23% |
| 1998 Q2 | 1.04 Billion USD | 8.66% |
| 1998 Q3 | 1.19 Billion USD | 22.03% |
| 1998 Q4 | 841 Million USD | -7.57% |
| 1997 FY | - USD | 8.45% |
| 1997 Q2 | 827 Million USD | -20.14% |
| 1997 Q3 | 954 Million USD | 22.3% |
| 1997 Q4 | 965 Million USD | -5.89% |
| 1997 Q1 | 1.04 Billion USD | 11.87% |
| 1996 Q1 | 910 Million USD | 10.05% |
| 1996 Q3 | 937 Million USD | 50.44% |
| 1996 Q4 | 922 Million USD | -2.83% |
| 1996 FY | - USD | 18.49% |
| 1996 Q2 | 680 Million USD | -29.68% |
| 1995 Q3 | 776.7 Million USD | 22.32% |
| 1995 Q1 | 746.5 Million USD | 6.43% |
| 1995 FY | - USD | 34.51% |
| 1995 Q4 | 781.6 Million USD | 4.45% |
| 1995 Q2 | 626.9 Million USD | -7.86% |
| 1994 Q4 | 581.3 Million USD | 22.45% |
| 1994 FY | - USD | 110.8% |
| 1994 Q3 | 581 Million USD | 23.26% |
| 1994 Q2 | 464.7 Million USD | -27.15% |
| 1994 Q1 | 636.6 Million USD | 161.28% |
| 1993 Q3 | 514.2 Million USD | 57.68% |
| 1993 Q2 | 616.8 Million USD | 40.69% |
| 1993 Q4 | -278.6 Million USD | -182.54% |
| 1993 FY | - USD | -25.49% |
| 1993 Q1 | 549.9 Million USD | 62.99% |
| 1992 FY | - USD | -9.83% |
| 1992 Q3 | 471.9 Million USD | 73.04% |
| 1992 Q2 | 338.9 Million USD | -42.93% |
| 1992 Q1 | 474.5 Million USD | -21.43% |
| 1992 Q4 | 422 Million USD | -22.35% |
| 1991 Q1 | 434 Million USD | 79.02% |
| 1991 Q2 | 308.7 Million USD | -31.66% |
| 1991 Q3 | 434.8 Million USD | 47.9% |
| 1991 Q4 | 320.5 Million USD | 40.47% |
| 1991 FY | - USD | 52.95% |
| 1990 FY | - USD | -0.4% |
| 1990 Q4 | 266.9 Million USD | -34.62% |
| 1990 Q3 | 385.2 Million USD | 47.25% |
| 1990 Q2 | 265.2 Million USD | -16.98% |
| 1990 Q1 | 362.5 Million USD | 108.88% |
| 1989 Q1 | 1.43 Billion USD | 147.79% |
| 1989 Q2 | 1.3 Billion USD | -9.3% |
| 1989 FY | - USD | 6.69% |
| 1989 Q4 | -3.2 Billion USD | -323.1% |
| 1989 Q3 | 1.43 Billion USD | 10.42% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbbVie Inc. | 26.35 Billion USD | 63.742% |
| Bristol-Myers Squibb Company | 19.41 Billion USD | 50.78% |
| Bristol-Myers Squibb Company Ce | 19.41 Billion USD | 50.78% |
| Johnson & Johnson | 23.72 Billion USD | 59.718% |
| Eli Lilly and Company | 8.56 Billion USD | -11.546% |
| Merck & Co., Inc. | 6.9 Billion USD | -38.367% |
| Novartis AG | 18.28 Billion USD | 47.736% |
| Organon & Co. | 1.43 Billion USD | -565.529% |